SC 13D/A:超过5%持股股东披露文件(修正)-1315 Capital II, L.P.(68%),1315 Capital Management II, LLC(68%)
SC 13D/A:超过5%持股股东披露文件(修正)-Ampersand 2018 Limited Partnership(76%),AMP-18 Management Company Limited Partnership(76%)等
D:发行公告
4:持股变动声明-股东 1315 Capital II, L.P.
4:持股变动声明-股东 Ampersand 2018 Limited Partnership
Interpace Biosciences Inc | SC 13G/A:超过5%持股股东披露文件(修正)-Douglas M. Singer(5.78%)
Interpace Biosciences Inc | 4:持股变动声明-高管 McCarthy Christopher
Interpace Biosciences Inc | 4:持股变动声明-首席财务官 McCarthy Christopher
Interpace Biosciences Inc | 3:首次持股声明-高管 McCarthy Christopher
Interpace Biosciences Inc | SC 13G/A:超过5%持股股东披露文件(修正)-Douglas M. Singer(8.32%)
Interpace Biosciences Inc | SC 13D/A:超过5%持股股东披露文件(修正)-Peter H. Kamin(18.6%)
Interpace Biosciences Inc | SC 13D/A:超过5%持股股东披露文件(修正)-Peter H. Kamin(18.6%)
Interpace Biosciences Inc | 4:持股变动声明
Interpace Biosciences Inc | SC 13D/A:超过5%持股股东披露文件(修正)
Interpace Biosciences Inc | 4:持股变动声明
Interpace Biosciences Inc | 4:持股变动声明
Interpace Biosciences Inc | 3:首次持股声明
Interpace Biosciences Inc | SC 13D:超过5%持股股东披露文件
Interpace Biosciences Inc | SC 13G/A:超过5%持股股东披露文件(修正)
Interpace Biosciences Inc | 4:持股变动声明